JE-2

The Japanese Encephalitis (JE) 2nd dose is given to children 12-24 months of age in areas at high risk for Japanese encephalitis. This dose provides extended protection against the mosquito-borne viral disease that causes brain inflammation and can lead to severe neurological consequences. The second dose ensures long-lasting immunity, complementing the first dose and contributing to the reduction of JE cases in endemic regions, protecting both children and communities from outbreaks.